Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The EGFR pathway as an example for genotype: phenotype correlation in tumor genes.

Methods in molecular biology (Clifton, N.J.) - 1 Jan 2010

Mogck Ulrike, Goekkurt Eray, Stoehlmacher Jan

Abstract excerpt

Tumor-specific and germ-line variations of DNA significantly contribute to tumor growth and its ability to develop resistance. Among several mechanisms that cause resistance to cancer treatment, the genotype of certain growth factors, like epidermal growth factor receptor (EGFR), is critical. EGF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to DNA, Neoplasm
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Genes, ras

Share to Neoplasms

Share to Polymorphism, Restriction Fragment Length

Share to ras Proteins

Source

Identifiers

PMID: 19882270
DOI: 10.1007/978-1-59745-545-9_17

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19882270-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The EGFR pathway as an example for genotype: phenotype correlation in tumor genes.PMID 19882270Read ↗

The EGFR R521K polymorphism influences the risk to develop colorectal cancer.Semantic proximity Read ↗

Pharmacogenetics of EGFR and VEGF inhibition.Semantic proximity Read ↗

Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer.Semantic proximity Read ↗

Assessment of K-ras mutation: a step toward personalized medicine for patients with colorectal cancer.Semantic proximity Read ↗

Mutations in the EGFR: the importance of genotyping.Semantic proximity Read ↗

Pharmacogenetics of small-molecule tyrosine kinase inhibitors: Optimizing the magic bullet.Semantic proximity Read ↗

Anti-EGFR therapy in colorectal cancer: how to choose the right patient.Semantic proximity Read ↗

Association of candidate single nucleotide polymorphisms with somatic mutation of the epidermal growth factor receptor pathway.Semantic proximity Read ↗

A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients.Semantic proximity Read ↗

Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancerSemantic proximity Read ↗

Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer.Semantic proximity Read ↗

Epidermal growth factor receptor (EGFR) status and K-Ras mutations in colorectal cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.